(VIANEWS) – Shares of Castle Biosciences (NASDAQ: CSTL) dropped 8.14% to $15.58 at 10:32 EST on Thursday, after five consecutive sessions in a row of losses. NASDAQ is jumping 2.5% to $11,099.15, after two consecutive sessions in a row of gains. This seems, up until now, an all-around positive trend exchanging session today.

Castle Biosciences’s last close was $16.96, 78.51% below its 52-week high of $78.92.


Today’s last reported volume for Castle Biosciences is 34329 which is 90.7% below its average volume of 369300.

The company’s growth estimates for the present quarter and the next is a negative 114.3% and a negative 68.1%, respectively.

Castle Biosciences’s Revenue

Year-on-year quarterly revenue growth grew by 44.7%, now sitting on 94.08M for the twelve trailing months.


Castle Biosciences’s last week, last month’s, and last quarter’s current intraday variation average was a negative 5.40%, a negative 0.05%, and a positive 5.08%, respectively.

Castle Biosciences’s highest amplitude of average volatility was 5.40% (last week), 5.24% (last month), and 5.08% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Castle Biosciences’s stock is considered to be overbought (>=80).

Castle Biosciences’s Stock Yearly Top and Bottom Value

Castle Biosciences’s stock is valued at $15.58 at 10:32 EST, under its 52-week low of $17.01.

Castle Biosciences’s Moving Average

Castle Biosciences’s worth is way under its 50-day moving average of $24.61 and way below its 200-day moving average of $44.68.

More news about Castle Biosciences (CSTL).


Please enter your comment!
Please enter your name here